- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/40 - Proteins from RNA viruses, e.g. flaviviruses
Patent holdings for IPC class C12N 15/40
Total number of patents in this class: 338
10-year publication summary
11
|
15
|
11
|
14
|
11
|
5
|
9
|
12
|
16
|
12
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Government of The United States of America AS represented by The Secretary of The Department of Health and Human Services | 168 |
6 |
Medicago Inc. | 138 |
6 |
Takeda Vaccines, Inc. | 223 |
6 |
The University of North Carolina at Chapel Hill | 2058 |
6 |
PnuVax Incorporated | 10 |
5 |
Regents of the University of Minnesota | 2711 |
5 |
The Regents of the University of California | 20137 |
4 |
The Trustees of the University of Pennsylvania | 4354 |
4 |
Folia Biotech Inc. | 10 |
4 |
Fundacao Oswaldo Cruz | 106 |
4 |
Icon Genetics GmbH | 46 |
4 |
Universite Laval | 717 |
4 |
University of Manitoba | 450 |
4 |
AlphaVax, Inc. | 23 |
3 |
Commonwealth Scientific and Industrial Research Organisation | 1670 |
3 |
The Government of The United States of America, AS represented by The secretary, Department of Health and Human Services | 83 |
3 |
Institut Pasteur | 787 |
3 |
The James Hutton Institute | 29 |
3 |
Kagoshima University | 310 |
3 |
Mitsubishi Tanabe Pharma Corporation | 580 |
3 |
Other owners | 255 |